Hemispherx Biopharma Inc

Hemispherx Biopharma, is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of viral and immune-based disorders. Hemispherx s flagship products include Alferon N Injection and the experimental immunotherapeutics/antivirals Ampligen and Oragens. Alferon N Injection is the company's registered trademark for its injectable formulation of Natural Alpha Interferon and is approved by the FDA for a category of STD infection. Alferon N Injection is a highly purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Alferon LDO is an experimental drug delivery platform for the company s highly purified, natural source alpha interferon. Headquartered in Philadelphia, Hemispherx BioPharma is a publicly owned company that employs nearly 60 people.